LeMaitre Q1 sales up 22% organic to $47.1M; EPS flat at $0.27; issues guidance

LEMAITRE VASCULAR INC

2023-Q1 EPS reported $0.27 revenue$47,075,000

Sales $47.1M, +19% (+22% organic); net income $6.0M flat; diluted EPS $0.27 (-1%).
Valvulotomes (+29%), carotid patches (+17%), bovine grafts (+22%), allografts (+42%), carotid shunts (+18%) led record Q1 sales.
Q2 2023 guidance: sales $47.1M–$49.5M; EPS $0.30–$0.35. Full year: sales $187.1M–$193.1M; EPS $1.14–$1.27.
Quarterly dividend $0.14/share, payable June 1, 2023 to holders of record May 17, 2023.
Agreed to distribute Aziyo porcine cardiac patches in US for three years (option to acquire); Aziyo's 2022 US patch sales $6.8M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LEMAITRE VASCULAR INC updated its the quarter ended March 31, 2023 guidance (initiated).

Period: the quarter ended March 31, 2023
Guidance: initiated
Result: preliminary results

Exact text from the filing

On May 2, 2023, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended March 31, 2023.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LEMAITRE VASCULAR INC reported Q1 2023 results: revenue $47.1mm, net income $6.0mm, EPS $0.27. Guidance initiated.

Period: Q1 2023
Revenue: $47.1mm
Net income: $6.0mm
EPS: $0.27
Guidance: initiated
Result: reported results

Exact text from the filing

devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance. Q1 2023 Financial Results ● Sales $47.1mm, +19% (+22% organic) vs. Q1 2022 ● Op. income $7.9mm, -1% ● Op. margin 17% ● Net income $6.0mm, flat ● Earnings per diluted share $0.27, -1%

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

LEMAITRE VASCULAR INC filing history →

Source: SEC EDGAR

accession 0001437749-23-012106

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.